AR051501A1 - Metodo para la deteccion de cancer - Google Patents

Metodo para la deteccion de cancer

Info

Publication number
AR051501A1
AR051501A1 ARP050104847A ARP050104847A AR051501A1 AR 051501 A1 AR051501 A1 AR 051501A1 AR P050104847 A ARP050104847 A AR P050104847A AR P050104847 A ARP050104847 A AR P050104847A AR 051501 A1 AR051501 A1 AR 051501A1
Authority
AR
Argentina
Prior art keywords
cancer
organism
subject
alkaloid
detection
Prior art date
Application number
ARP050104847A
Other languages
English (en)
Inventor
Wassyl Nowicky
Original Assignee
Ddr Wassyl Nowicky Dipl Ing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ddr Wassyl Nowicky Dipl Ing filed Critical Ddr Wassyl Nowicky Dipl Ing
Publication of AR051501A1 publication Critical patent/AR051501A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Abstract

Un método para la deteccion de cáncer en el organismo de un sujeto humano, que está basado en la determinacion de la concentracion de un derivado alcaloide que se adhiere a células cancerosas o se acumula en las mismas en muestras de sangre y/u orina de sujetos después de la administracion oral o parenteral de dicho derivado alcaloide a dicho sujeto, donde una reduccion de dichos valores de concentracion en comparacion con valores correspondientes en sujetos sanos indica la presencia de células cancerosas en el organismo del sujeto. Se describe además un equipo de diagnostico para llevar a cabo el método y para el uso de dichos derivaos alcaloides como herramientas diagnosticas en el diagnostico de cáncer. La presente se refiere también a un método para la localizacion de cáncer en el organismo de un ser humano, donde dicho método está basado en la administracion de derivados alcaloides marcados con metales a un paciente con cáncer y la posterior deteccion de los mismos usando métodos físicos de deteccion conocidos.
ARP050104847A 2004-11-19 2005-11-18 Metodo para la deteccion de cancer AR051501A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04027574 2004-11-19

Publications (1)

Publication Number Publication Date
AR051501A1 true AR051501A1 (es) 2007-01-17

Family

ID=35788395

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104847A AR051501A1 (es) 2004-11-19 2005-11-18 Metodo para la deteccion de cancer

Country Status (2)

Country Link
AR (1) AR051501A1 (es)
WO (1) WO2006053649A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015144900A1 (de) * 2014-03-27 2015-10-01 Nowicky Wassili Diagnoseverfahren zur krebsfrüherkennung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US5399338A (en) * 1991-05-01 1995-03-21 University Of New Mexico Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
FR2694193B1 (fr) * 1992-07-28 1994-10-28 Abraxas Bio Labs Sa Méthode de cytodiagnostic utilisant l'alstonine comme marqueur sélectif et kit de diagnostic contenant ce marqueur.
SI1098641T1 (sl) * 1998-07-27 2016-08-31 St. Jude Pharmaceuticals, Inc. Kemično inducirana intracelularna hipertermija
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.

Also Published As

Publication number Publication date
WO2006053649A1 (en) 2006-05-26

Similar Documents

Publication Publication Date Title
IL192166A (en) A facility for quantitative and qualitative measurement of body fluid
AR107561A2 (es) Ensayo elisa para la detección de vegf
WO2006073682A3 (en) Diagnostic test
DE60228755D1 (de) Verfahren und vorrichtung zur überwachung der analytkonzentration durch optischen nachweis
NO20053168D0 (no) Anordning og fremstilling av medisinske innretninger.
AR048031A1 (es) Metodos para estimar la necesidad y efectividad de la terapia con antioxidantes
CY1105322T1 (el) Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων
Pishnamazi et al. Quality of life in burn patients
WO2005012553A3 (en) Optical in vivo probe of analyte concentration within the sterile matrix under the human nail
WO2006033715A3 (en) Portable sampling or testing device and method for pharmacokinetics and physiology studies
EP3879269A3 (en) Methods of measuring signaling pathway activity for selection of therapeutic agents
EA201590686A1 (ru) Тест на митохондриальную токсичность
WO2004112567A3 (en) Methods, device and system for in vivo detection
Abdoli et al. Barriers to and Facilitators of Empowerment in People with Diabetes
WO2006097933A3 (en) Method for monitoring changes in blood glucose level
AR051501A1 (es) Metodo para la deteccion de cancer
La Favor et al. A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues
Lee et al. The Korean version of relative and absolute reliability of gait and balance assessment tools for patients with dementia in day care center and nursing home
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal
Carter-Snell et al. Forensic ultraviolet lights in clinical practice: evidence for the evidence
AR051502A1 (es) Metodo diagnostico ex vivo del cancer
Shmarlouski et al. A novel analysis technique for transcutaneous measurement of glomerular filtration rate with ultralow dose marker concentrations
WO2009148363A3 (ru) Способ диагностики паразитарного заболевания
Sasaki-Saito Multiple fixed drug eruption: case report
Lafontant et al. Blood flow analysis for prediction of pressure ulcer development using diffuse correlation spectroscopy

Legal Events

Date Code Title Description
FB Suspension of granting procedure